Back to discover
Disease
Dermatitis, Contact
Late-stage therapeutic developmentEmerging research
2
Publications
4
Clinical trials
2009
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
Research2009-05-01Journal of immunology (Baltimore, Md. : 1950)
Research2002-04-01Journal of immunology (Baltimore, Md. : 1950)
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
No activity recorded in this window. Try a wider timeframe.
Clinical trials
The current development programme across all trial phases.
Clinical programme
4
0
1
2
Late-stage studies
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Publications over time
20022009
Most influential
Leading journals1
- Journal of immunology (Baltimore, Md. : 1950)2
Leading researchers8
- Boon L1
- Cornelissen F1
- Dufour JH1
- Dziejman M1
- Florencia E1
- Kant M1
- Laman JD1
- Lane TE1
Affiliations (unnormalised)2
- Center for Immunology and Inflammatory Diseases1
- Erasmus Medical Center1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.